The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| GDR | -51.61% | -99.08% | -60.85% | -99% |
| S&P | +14.43% | +77.25% | +12.13% | +379% |
Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. It operates through the Diagnostics segment, which is responsible for the commercialization of the Genedrive Point of Need molecular testing platform. The company was founded by Catherine Booth and Christopher Potten on February 15, 2007 and is headquartered in Manchester, the United Kingdom.
No news articles found for Genedrive Plc.
No data available for this period.
Currently no data to display
Currently no data to display.
Currently no data to display.
No data available for this period.
No data available for this period.
No data available for this period.
No data available for this period.
| Metric | YoY Change |
|---|
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
